Pharmacogenetic associations of β1-adrenergic receptor polymorphisms with cardiovascular outcomes in the SPS3 trial

BACKGROUND AND PURPOSE: Functional polymorphisms (Ser49Gly and Arg389Gly) in ADRB1 have been associated with cardiovascular and β-blocker response outcomes. Herein we examined associations of these polymorphisms with Major Adverse Cardiovascular Events (MACE), with and without stratification by β-bl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stroke
Main Authors: Magvanjav, Oyunbileg, McDonough, Caitrin W., Gong, Yan, McClure, Leslie A., Talbert, Robert L., Horenstein, Richard B., Shuldiner, Alan R., Benavente, Oscar R., Mitchell, Braxton D., Johnson, Julie A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404951/
https://ncbi.nlm.nih.gov/pubmed/28351962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.015936
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados